US 7825127
Method for treating cancer
granted A61KA61K31/517A61K31/519
Quick answer
US patent 7825127 (Method for treating cancer) held by Takeda Pharmaceutical Company Limited expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/517, A61K31/519, A61P, A61P35/00